NovaBridge Biosciences Files 6-K Report
Ticker: NBP · Form: 6-K · Filed: Apr 22, 2026 · CIK: 0001778016
Sentiment: neutral
Topics: 6-K, foreign-issuer, regulatory-filing
TL;DR
NovaBridge Biosciences dropped a 6-K filing on 4/22/26 - check the docs for updates.
AI Summary
NovaBridge Biosciences filed a Form 6-K on April 22, 2026, reporting information as a foreign issuer. The filing includes documents such as a press release and exhibits, with a total submission size of 693,270 bytes.
Why It Matters
This filing provides updated information for investors and regulatory bodies regarding NovaBridge Biosciences' operations as a foreign issuer.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign issuers and typically does not contain significant new material information that would immediately impact risk.
Key Numbers
- 693270 bytes — Submission Size (Total size of the complete submission text file.)
Key Players & Entities
- NovaBridge Biosciences (company) — Filer
- 0001778016 (company) — CIK number
- 2026-04-22 (date) — Filing Date and Period of Report
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC under Rules 13a-16 and 15d-16, used to submit information that the issuer makes or is required to make public in its home country.
When was this specific Form 6-K filed?
This Form 6-K was filed on April 22, 2026.
What are the key documents included in this filing?
The filing includes a press release (mark_hagler_pr_-_04-22-2.htm), an exhibit (nbp-ex99_1.htm), and a graphic file (img62529193_0.jpg).
What is NovaBridge Biosciences' CIK number?
NovaBridge Biosciences' CIK number is 0001778016.
What is the business address of NovaBridge Biosciences?
The business address is SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2026 regarding NovaBridge Biosciences (NBP).